{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:29:01Z","timestamp":1740180541002,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with rheumatologic diseases are monitored fundamentally through metric tools or index calculated from clinical data and patient exams, which allow us to assess the severity of the disease and guide the therapeutic decision. In rheumatoid arthritis (RA), for treatment to be optimized and considered effective, periodic assessment with composite disease activity index and a 'treat-to-target' approach is required. The Routine Assessment of Patient Index Data 3 (RAPID3) in the Multidimensional Health Assessment Questionnaire (MDHAQ) includes only three measures based on the central patient self-reported dataset and can be used in a 'treat-to-target' approach analogous to the Clinical Disease Activity Index (CDAI) and the Disease Activity Score 28-joints (DAS28). This tool, however, has not undergone cross-cultural or clinical validation in Brazil. In this research, we performed the MDHAQ cross-cultural and clinical validation for the Brazilian population of RA patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Portuguese version of the MDHAQ was created identically in an electronic questionnaire and underwent a cross-cultural validation process with 38 participants. Test\u2013retest was performed in 29 patients. Further, a clinical validation with 129 Rheumatoid Arthritis patients was performed. Electronic MDHAQ was answered through an online platform. We also collected socioeconomic data as well as other clinical (CDAI, SDAI, DAS28) and functional (HAQ) scores during the face-to-face assessment of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MDHAQ\/RAPID3 maintained semantic, idiomatic, as well as conceptual and experience equivalence for the Brazilian population, with 92% acceptance of participants. It showed test\u2013retest reliability, adequate internal consistency (Cronbach's \u03b1 0.85) and correlation of the scores obtained with adequate association with the DAS28 gold standard. RAPID3 also had high sensitivity (98%), adequate specificity (48%), high negative predictive value (92%) and negative post-test probability of 8%, attributes expected for a test tool for population screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The use of MDHAQ\/RAPID3 associated with traditional clinical measures can adequately allow for remote follow-up based on the 'treat-to-target' approach with performance comparable to the gold standard DAS28, being a viable tool in the sample of Brazilian patients with RA in the current context of telehealth.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-022-00278-9","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:13:11Z","timestamp":1669180391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cross-cultural and clinical validation of the MDHAQ\/RAPID3 questionnaire in electronic format for a Brazilian population of patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5825-6031","authenticated-orcid":false,"given":"Ilka Benedet","family":"Lineburger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claiton Viegas","family":"Brenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Silveira","family":"Goularte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edila Penna","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia Naomi","family":"Hirakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"278_CR1","first-page":"S7","volume":"30","author":"Y Yazici","year":"2012","unstructured":"Yazici Y. Treat-to-target: measures. Clin Exp Rheumatol. 2012;30:S7\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"278_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24114","author":"S Desai","year":"2019","unstructured":"Desai S, Leatherwood C, Forman M, Ko E, Stevens E, Iversen M, Xu C, Lu B, Solomon DH. Treat-to-target in rheumatoid arthritis: a quality improvement trial. Arthritis Care Res. 2019. https:\/\/doi.org\/10.1002\/acr.24114.","journal-title":"Arthritis Care Res"},{"key":"278_CR3","first-page":"S50","volume":"30","author":"I Castrej\u00f3n","year":"2012","unstructured":"Castrej\u00f3n I, Pincus T. Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis. Clin Exp Rheumatol. 2012;30:S50\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"278_CR4","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/rheumatology\/ket230","volume":"52","author":"I Castrej\u00f3n","year":"2013","unstructured":"Castrej\u00f3n I, Pincus T, Soubrier M, Lin YC, Rat A-CC, Combe B, Dougados M. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate. Rheumatology (United Kingdom). 2013;52:1890\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/ket230.","journal-title":"Rheumatology (United Kingdom)"},{"key":"278_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137. https:\/\/doi.org\/10.1136\/ard.2009.123919.","journal-title":"Ann Rheum Dis"},{"key":"278_CR6","first-page":"177","volume":"70","author":"T Pincus","year":"2012","unstructured":"Pincus T, Skummer PT, Grisanti MT, Castrej\u00f3n I, Yazici Y. MDHAQ\/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Bull NYU Hosp Jt Dis. 2012;70:177\u201386.","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"Suppl 1","key":"278_CR7","first-page":"30","volume":"70","author":"T Pincus","year":"2012","unstructured":"Pincus T, Yazici Y, Castrej\u00f3n I. Pragmatic and scientific advantages of MDHAQ\/ RAPID3 completion by all patients at all visits in routine clinical care. Bull NYU Hosp Jt Dis. 2012;70(Suppl 1):30\u20136.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"278_CR8","first-page":"254","volume":"67","author":"T Pincus","year":"2009","unstructured":"Pincus T. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? Bull NYU Hosp Jt Dis. 2009;67:254\u201366.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"278_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24429","author":"BR England","year":"2020","unstructured":"England BR, Barber CEH, Bergman M, Ranganath VK, Suter LG, Michaud K. Brief report: adaptation of American College of Rheumatology rheumatoid arthritis disease activity and functional status measures for telehealth visits. Arthritis Care Res. 2020. https:\/\/doi.org\/10.1002\/acr.24429.","journal-title":"Arthritis Care Res"},{"key":"278_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/acr.24042","volume":"71","author":"BR England","year":"2019","unstructured":"England BR, Tiong BK, Bergman MJ, Curtis JR, Kazi S, Mikuls TR, O\u2019Dell JR, Ranganath VK, Limanni A, Suter LG, Michaud K. 2019 Update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res. 2019;71:1540\u201355. https:\/\/doi.org\/10.1002\/acr.24042.","journal-title":"Arthritis Care Res"},{"key":"278_CR11","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","volume":"25","author":"DE Beaton","year":"2000","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186\u201391. https:\/\/doi.org\/10.1097\/00007632-200012150-00014.","journal-title":"Spine"},{"key":"278_CR12","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1590\/S1413-81232011000800006","volume":"16","author":"NMC Alexandre","year":"2011","unstructured":"Alexandre NMC, Coluci MZO. Validade de conte\u00fado nos processos de constru\u00e7\u00e3o e adapta\u00e7\u00e3o de instrumentos de medidas. Ciencia e Saude Coletiva. 2011;16:3061\u20138. https:\/\/doi.org\/10.1590\/S1413-81232011000800006.","journal-title":"Ciencia e Saude Coletiva"},{"key":"278_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00006199-198611000-00017","volume":"35","author":"MR Lynn","year":"1986","unstructured":"Lynn MR. Determination and quantification of content validity. Nurs Res. 1986;35:382\u20136.","journal-title":"Nurs Res"},{"key":"278_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/nur.20199","volume":"30","author":"DF Polit","year":"2007","unstructured":"Polit DF, Beck CT, Owen SV. Focus on research methods: Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30:459\u201367. https:\/\/doi.org\/10.1002\/nur.20199.","journal-title":"Res Nurs Health"},{"key":"278_CR15","doi-asserted-by":"crossref","unstructured":"Lewis JR, Sauro J. The factor structure of the system usability scale. In: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 94\u2013103; 2009.","DOI":"10.1007\/978-3-642-02806-9_12"},{"key":"278_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.rdc.2009.10.006","volume":"35","author":"D Aletaha","year":"2009","unstructured":"Aletaha D, Smolen JS. The simplified disease activity index and clinical disease activity index to monitor patients in standard clinical care. Rheum Dis Clin N Am. 2009;35:759\u201372. https:\/\/doi.org\/10.1016\/j.rdc.2009.10.006.","journal-title":"Rheum Dis Clin N Am"},{"key":"278_CR17","first-page":"603","volume":"35","author":"Y Yazici","year":"2008","unstructured":"Yazici Y, Bergman M, Pincus T. Time to score quantitative rheumatoid arthritis measures: 28-joint count, disease activity score, health assessment questionnaire (HAQ), multidimensional HAQ (MDHAQ), and routine assessment of patient index data (RAPID) scores. J Rheumatol. 2008;35:603\u20139.","journal-title":"J Rheumatol"},{"key":"278_CR18","doi-asserted-by":"publisher","first-page":"e15815","DOI":"10.2196\/15815","volume":"4","author":"T Pincus","year":"2020","unstructured":"Pincus T, Castrejon I, Riad M, Obreja E, Lewis C, Krogh NS. Reliability, feasibility, and patient acceptance of an electronic version of a multidimensional health assessment questionnaire for routine rheumatology care: validation and patient preference study. JMIR Form Res. 2020;4:e15815. https:\/\/doi.org\/10.2196\/15815.","journal-title":"JMIR Form Res"},{"key":"278_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s10067-016-3521-5","volume":"36","author":"JGB Mu\u00f1oz","year":"2017","unstructured":"Mu\u00f1oz JGB, Giraldo RB, Santos AM, Bello-Gualteros JM, Rueda JC, Saldarriaga E-LL, Angarita J-II, Arias-Correal S, Vasquez AY, Londono J. Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis. Clin Rheumatol. 2017;36:1143\u20138. https:\/\/doi.org\/10.1007\/s10067-016-3521-5.","journal-title":"Clin Rheumatol"},{"key":"278_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3109\/14397595.2014.948587","volume":"25","author":"N Yokogawa","year":"2015","unstructured":"Yokogawa N, Kaneko T, Nagai Y, Nunokawa T, Sawaki T, Shiroto K, Shimada K, Sugii S. Validation of RAPID3 using a Japanese version of multidimensional health assessment questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI. Mod Rheumatol. 2015;25:264\u20139. https:\/\/doi.org\/10.3109\/14397595.2014.948587.","journal-title":"Mod Rheumatol"},{"key":"278_CR21","first-page":"S19","volume":"23","author":"T Pincus","year":"2005","unstructured":"Pincus T, Yazici Y, Bergman M. Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol. 2005;23:S19.","journal-title":"Clin Exp Rheumatol"},{"key":"278_CR22","volume-title":"Practical statistics for medical research","author":"DG Altman","year":"1991","unstructured":"Altman DG. Practical statistics for medical research. London: Chapman and Hall\/CRC; 1991."},{"key":"278_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1207\/S15327752JPA8001_18","volume":"80","author":"DL Streiner","year":"2003","unstructured":"Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80:99\u2013103. https:\/\/doi.org\/10.1207\/S15327752JPA8001_18.","journal-title":"J Pers Assess"},{"issue":"2","key":"278_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"278_CR25","doi-asserted-by":"publisher","first-page":"1759720X2110118","DOI":"10.1177\/1759720X211011826","volume":"13","author":"S Bugatti","year":"2021","unstructured":"Bugatti S, de Stefano L, Manzo A, Sakellariou G, Xoxi B, Montecucco C. Limiting factors to Boolean remission differ between autoantibody-positive and negative patients in early rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2021;13:1759720X2110118. https:\/\/doi.org\/10.1177\/1759720X211011826.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s10067-018-4077-3","volume":"37","author":"V Strand","year":"2018","unstructured":"Strand V, Lee EB, Yazici Y, Dikranian A, Wilkinson B, Takiya L, Zang C, Bananis E, Bergman MJ. Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials. Clin Rheumatol. 2018;37:2043\u201353. https:\/\/doi.org\/10.1007\/s10067-018-4077-3.","journal-title":"Clin Rheumatol"},{"key":"278_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.rdc.2009.10.008","volume":"35","author":"T Pincus","year":"2009","unstructured":"Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin N Am. 2009;35:773\u20138. https:\/\/doi.org\/10.1016\/j.rdc.2009.10.008.","journal-title":"Rheum Dis Clin N Am"},{"key":"278_CR28","doi-asserted-by":"publisher","first-page":"6940401","DOI":"10.1155\/2019\/6940401","volume":"2019","author":"MF Zurita","year":"2019","unstructured":"Zurita MF, Iglesias A, Vanegas E, Luzuriaga A, Zurita L. Measurement of disease activity in ecuadorian patients with rheumatoid arthritis: Does RAPID3 correlate with traditional indexes? Sci World J. 2019;2019:6940401. https:\/\/doi.org\/10.1155\/2019\/6940401.","journal-title":"Sci World J"},{"key":"278_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1109\/MEI.2017.7956625","volume":"33","author":"H Wintle","year":"2017","unstructured":"Wintle H. RAPID3 correlates with ESSPRI and other patient-reported outcomes in patients with primary Sj\u00f6gren\u2019s syndrome. IEEE Electr Insul Mag. 2017;33:6. https:\/\/doi.org\/10.1109\/MEI.2017.7956625.","journal-title":"IEEE Electr Insul Mag"},{"key":"278_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/RHU.0b013e3181b40a9a","volume":"15","author":"T Pincus","year":"2009","unstructured":"Pincus T. Is a self-report RAPID3 score a reasonable alternative to a DAS28 in usual clinical care? J Clin Rheumatol. 2009;15:215\u20137.","journal-title":"J Clin Rheumatol"},{"key":"278_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/acr2.11053","volume":"1","author":"J Schmukler","year":"2019","unstructured":"Schmukler J, Jamal S, Castrejon I, Block JA, Pincus T. Fibromyalgia assessment screening tools (FAST) based on only multidimensional health assessment questionnaire (MDHAQ) scores as clues to fibromyalgia. ACR Open Rheumatol. 2019;1:516\u201325. https:\/\/doi.org\/10.1002\/acr2.11053.","journal-title":"ACR Open Rheumatol"},{"key":"278_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00296-014-3042-y","volume":"34","author":"S-KK Kim","year":"2014","unstructured":"Kim S-KK, Park S-HH, Bae J, Son JT, Choe J-YY. Performance of routine assessment of patient index data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories. Rheumatol Int. 2014;34:1311\u20138. https:\/\/doi.org\/10.1007\/s00296-014-3042-y.","journal-title":"Rheumatol Int"},{"key":"278_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jbspin.2011.03.014","volume":"79","author":"M Bossert","year":"2012","unstructured":"Bossert M, Prati C, Vidal C, Bongain S, Toussirot E, Wendling D. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients. Joint Bone Spine. 2012;79:57\u201362. https:\/\/doi.org\/10.1016\/j.jbspin.2011.03.014.","journal-title":"Joint Bone Spine"},{"key":"278_CR34","first-page":"1","volume":"1","author":"WHO","year":"2020","unstructured":"WHO. Screening programmes: a short guide. WHO Press. 2020;1:1\u201370.","journal-title":"WHO Press"},{"key":"278_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3109\/08958378.2014.955932","volume":"26","author":"LD Maxim","year":"2014","unstructured":"Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhalation Toxicol. 2014;26:811\u201328. https:\/\/doi.org\/10.3109\/08958378.2014.955932.","journal-title":"Inhalation Toxicol"},{"key":"278_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/RHU.0000000000000778","volume":"25","author":"PR Wood","year":"2019","unstructured":"Wood PR, Caplan L. Outcomes, satisfaction, and costs of a rheumatology telemedicine program: a longitudinal evaluation. J Clin Rheumatol. 2019;25:41\u20134. https:\/\/doi.org\/10.1097\/RHU.0000000000000778.","journal-title":"J Clin Rheumatol"},{"key":"278_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jbspin.2010.08.009","volume":"77","author":"A Blanchais","year":"2010","unstructured":"Blanchais A, Berthelot J-M, Fontenoy A-M, le Goff B, Maugars Y. Weekly home self-assessment of RAPID-4\/3 scores in rheumatoid arthritis: a 6-month study in 26 patients. Joint Bone Spine. 2010;77:582\u20137. https:\/\/doi.org\/10.1016\/j.jbspin.2010.08.009.","journal-title":"Joint Bone Spine"},{"key":"278_CR38","first-page":"136","volume":"72","author":"I Castrej\u00f3n","year":"2014","unstructured":"Castrej\u00f3n I, Pincus T. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes\u2013advantages of using RAPID3\/MDHAQ in routine care. Bull Hosp Jt Dis. 2014;72:136\u201341.","journal-title":"Bull Hosp Jt Dis"},{"key":"278_CR39","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/acr.24049","volume":"72","author":"ED Ferucci","year":"2020","unstructured":"Ferucci ED, Holck P, Day GM, Choromanski TL, Freeman SL. Factors associated with use of telemedicine for follow-up of rheumatoid arthritis. Arthritis Care Res. 2020;72:1404\u20139. https:\/\/doi.org\/10.1002\/acr.24049.","journal-title":"Arthritis Care Res"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-022-00278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-022-00278-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-022-00278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:22:41Z","timestamp":1669180961000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-022-00278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1186\/s42358-022-00278-9","relation":{},"ISSN":["2523-3106"],"issn-type":[{"type":"electronic","value":"2523-3106"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received Ethical Approval from Hospital de Cl\u00ednicas de Porto Alegre and all patients completed a Consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have the author\u2019s consent for use of MDHAQ\/RAPID3 and publication mention in the main manuscript for his original publication was cited as Reference.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We do not share any competing interests for this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}